-
Product Insights
C-C Chemokine Receptor Type 8 – Drugs In Development, 2023
Global Markets Direct’s C-C Chemokine Receptor Type 8 provides in depth analysis on C-C Chemokine Receptor Type 8 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-C...
-
Product Insights
C-C Chemokine Receptor Type 5 – Drugs In Development, 2023
Global Markets Direct’s C-C Chemokine Receptor Type 5 provides in depth analysis on C-C Chemokine Receptor Type 5 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-C...
-
Product Insights
C-C Chemokine Receptor Type 2 – Drugs In Development, 2023
Global Markets Direct’s C-C Chemokine Receptor Type 2 provides in depth analysis on C-C Chemokine Receptor Type 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-C...
-
Product Insights
C-C Chemokine Receptor Type 4 – Drugs In Development, 2023
Global Markets Direct’s C-C Chemokine Receptor Type 4 provides in depth analysis on C-C Chemokine Receptor Type 4 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-C...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – C-005 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - C-005 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. C-005 in Non-Small Cell Lung Cancer Drug Details: C-005 is...
-
Product Insights
C-X-C Chemokine Receptor Type 4 – Drugs In Development, 2023
Global Markets Direct’s C-X-C Chemokine Receptor Type 4 provides in depth analysis on C-X-C Chemokine Receptor Type 4 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-C...
-
Product Insights
C-X-C Chemokine Receptor Type 2 – Drugs In Development, 2023
Global Markets Direct’s C-X-C Chemokine Receptor Type 2 provides in depth analysis on C-X-C Chemokine Receptor Type 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-C...
-
Product Insights
C-X-C Chemokine Receptor Type 3 – Drugs In Development, 2023
Global Markets Direct’s C-X-C Chemokine Receptor Type 3 provides in depth analysis on C-X-C Chemokine Receptor Type 3 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-C...
-
Product Insights
C-X-C Chemokine Receptor Type 1 – Drugs In Development, 2023
Global Markets Direct’s C-X-C Chemokine Receptor Type 1 provides in depth analysis on C-X-C Chemokine Receptor Type 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-C...
-
Product Insights
C-X-3-C Motif Chemokine Receptor – Drugs In Development, 2023
Global Markets Direct’s C-X-3-C Motif Chemokine Receptor provides in depth analysis on C-X-3-C Motif Chemokine Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-3-C Motif Chemokine...